Home › Quitting Smoking (Tobacco Use Disorder) › NCT05962229
Comparative Pharmacokinetics and Pharmacodynamics of Synthetic Nicotine
RecruitingPhase 1Healthy volunteers welcome
Who can join
Ages 21 to 65 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria:
* Healthy on the basis of medical history and limited physical examination.
* Current regular user of E-Cigarettes (≥ 15 days in the past 30 days)
Exclusion Criteria:
* • Medications
* Use of medications that are inducers of nicotine metabolizing enzyme CYP2A6 (Example: rifampicin, carbamazepine, phenobarbital, and other anticonvulsant drugs).
* Use of sympatholytic medications for cardiovascular conditions including hypertension (Example: beta and alpha-blockers).
* Concurrent use of nicotine-containing medications (Example: nicotine patch, lozenge, gum).
* Any stimulant medications (example: Adderall) generally given for ADHD treatment.
• Pregnancy
* Pregnancy (self-reported and urine pregnancy test)
* Breastfeeding (determined by self-report)
* Women of childbearing potential must be using an acceptable method of contraception
* Inability to read and write in English
* A known propylene glycol/vegetable glycerin allergy
* Uncomfortable with getting blood drawnAbout the study
In a crossover study, experienced electronic cigarette users will vape 3 different forms of nicotine: natural (derived from tobacco), synthetic, or a 50:50 mixture of both natural and synthetic. The investigators will compare nicotine metabolism, cardiovascular effects, patterns of self-administration, and participants' feelings of craving/withdrawal and enjoyment.
What is being tested
- (S)-Nicotine (drug)
- (R)- nicotine (drug)
- Racemic nicotine (drug)
Sponsor: University of California, San Francisco · Participants: 18 · Started: Dec 6, 2024
Contact the study team
- Lisa Lawrence · Phone: 628-206-4204
- Armando Barraza · Phone: 510-560-4842
Official record on ClinicalTrials.gov — NCT05962229
Locations in the U.S.
| California | Zuckerberg San Francisco General Hospital (ZSFG), San Francisco |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.